RYTM
Rhythm Pharmaceuticals Inc
NASDAQ: RYTM · HEALTHCARE · BIOTECHNOLOGY
$82.12
-2.45% today
Updated 2026-04-29
Market cap
$5.61B
P/E ratio
—
P/S ratio
29.55x
EPS (TTM)
$-3.11
Dividend yield
—
52W range
$55 – $122
Volume
0.9M
Rhythm Pharmaceuticals Inc (RYTM) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+11.6%
Last 4 quarters
Revenue YoY growth
+36.9%
Most recent quarter
EPS YoY growth
-1.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.6%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-12.5%
2025-11-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-04 | $-0.73 | +11.2% | $89.56 | $91.46 | +2.1% |
| 2025-11-04 | $-0.82 | -15.5% | $113.74 | $99.47 | -12.5% |
| 2025-08-05 | $-0.75 | -11.9% | $90.24 | $90.01 | -0.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.82 | $-0.73 | +11.2% | $57.25M | +36.9% |
| 2025-09-30 | $-0.71 | $-0.82 | -15.5% | $51.30M | +54.3% |
| 2025-06-30 | $-0.67 | $-0.75 | -11.9% | $48.50M | +66.8% |
| 2025-03-31 | $-2.16 | $-0.81 | +62.5% | $32.70M | +25.9% |
| 2024-12-31 | $-0.73 | $-0.72 | +1.4% | $41.83M | +72.6% |
| 2024-09-30 | $-0.80 | $-0.73 | +8.8% | $33.25M | +47.8% |
| 2024-06-30 | $-0.71 | $-0.69 | +2.8% | $29.08M | +51.3% |
| 2024-03-31 | $-2.16 | $-2.35 | -8.8% | $25.97M | — |
| 2023-12-31 | $-0.70 | $-0.70 | +0.0% | $24.23M | — |
| 2023-09-30 | $-0.74 | $-0.76 | -2.7% | $22.50M | — |
| 2023-06-30 | $-0.79 | $-0.82 | -3.8% | $19.22M | — |
Frequently asked questions
Has Rhythm Pharmaceuticals Inc beaten earnings estimates?
Rhythm Pharmaceuticals Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +11.6% over the last 4 quarters.
How does RYTM stock react to earnings?
RYTM stock has moved an average of -3.6% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Rhythm Pharmaceuticals Inc's revenue growth rate?
Rhythm Pharmaceuticals Inc reported year-over-year revenue growth of +36.9% in its most recent quarter, with EPS growing -1.4% year-over-year.